Notizie AIOM – anno XV
New ASCO Guideline Aims to Improve Clinician Communication With Patients
September 19, 2017 - A new guideline from ASCO published by Gilligan et al in the Journal of Clinical Oncology outlines best practices for cancer clinicians when communicating with patients and their loved ones. The Patient-Clinician Communication: American Society of Clinical ...Leggi tutto
FDA Approves Reduced Dose of Cabazitaxel for mCRPC
September 18, 2017 - The FDA has approved a cabazitaxel regimen of 20 mg/m2 every 3 weeks in combination with prednisone for the treatment of men with metastatic castration-resistant prostate cancer who previously received a docetaxel-containing regimen. The agency approved ...Leggi tutto
FDA Panel Splits on Adjuvant Sunitinib in High-Risk RCC
September 19, 2017 - The FDA’s Oncologic Drugs Advisory Committee (ODAC) voted 6-6 on the potential approval of sunitinib for use as an adjuvant therapy in patients with renal cell carcinoma (RCC) who have received nephrectomy and are at high risk of recurrence. The ...Leggi tutto
FDA clears first duodenoscope with disposable distal cap
September 20, 2017 - The U.S. Food and Drug Administration today cleared the first duodenoscope with a disposable distal cap, a new feature that will improve access for cleaning and reprocessing. The Pentax ED34-i10T model duodenoscope is intended to provide visualization ...Leggi tutto
EU Approves Midostaurin for AML, Advanced Systemic Mastocytosis
September 20, 2017 - The European Commission has approved midostaurin for adults with newly diagnosed FLT3-positive acute myeloid leukemia (AML) and advanced systemic mastocytosis (SM), including aggressive systemic mastocytosis (SM), SM with associated hematological neoplasm ...Leggi tutto
Web-app
Una nuova web-app gratuita, in otto lingue, per computer, tablet e smartphone sul tumore del pancreas è disponibile sul sito del Corriere della Sera in collaborazione con l'Associazione Italiana di Oncologia Medica (leggi e scarica). Strumento interattivo in due versioni, ...Leggi tutto
NCCN Guidelines to Include Categories of Preference
September 15, 2017 - The National Comprehensive Cancer Network® (NCCN®) has instituted Categories of Preference for recommendations within the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Initially, Categories of Preference will be published ...Leggi tutto